Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001649904-26-000030

Director sold 10,000 shares at an average $109.66 ($1,096,550)

  • Director acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

JEAN CHRISTOPHE · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-17 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $34.89 $348,900 21,712 D
2026-11-17 Sale : show line 2 in the form 10b5-1 −5,000 $106.81 $534,050 16,712 D
2026-11-17 Sale : show line 3 in the form 10b5-1 −2,500 $110.00 $275,000 14,212 D
2026-11-17 Sale : show line 4 in the form 10b5-1 −2,500 $115.00 $287,500 11,712 D
Open-market sales · 10,000 sh · avg $109.66 · $1,096,550

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2026-11-17 Exercise or conversion : show line 5 in the form 10b5-1 Stock Options (Right to Buy) −10,000 $34.89 2028-06-05 10,000 0 D
Loading xslF345X06/form4.xml…